Evolus EOLS
NASDAQ EOLS
$8.35 -0.25 (-2.85%)
At close: Aug 20, 2026 · 2:52 PM UTC

Evolus (EOLS) FCF Margin (2019 - 2026)

Evolus' (EOLS) quarterly FCF Margin came in at 13.62% in Q1 2026, up 965.0% YoY from 1.28% in Q1 2025, and down 201.34% on a QoQ basis from 13.44% in Q4 2025.

Evolus (EOLS) FCF Margin (2019 - 2026) Analysis & Trends

Evolus (EOLS) has 8 years of FCF Margin data on file, last reported at 13.62% in Q1 2026.

  • Quarterly FCF Margin rose 965.0% year-over-year to 13.62% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.68% (down 477.0% YoY) and the FY2025 annual result came in at 15.91%, down 860.0% from the prior year.
  • FCF Margin retreated to 13.62% in Q1 2026, from 13.44% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 13.44% in Q4 2025 to a low of 112.69% in Q1 2022.
  • A 5-year average of 25.98% and a median of 22.09% in 2022 frame the typical range for FCF Margin.
  • The widest YoY moves for FCF Margin: up 7124 bps in 2022, down 11901 bps in 2022.
  • Tracing EOLS's FCF Margin over 5 years: stood at 22.09% in 2022, then soared by 105 bps to 1.08% in 2023, then jumped by 411 bps to 5.54% in 2024, then jumped by 143 bps to 13.44% in 2025, then tumbled by 201 bps to 13.62% in 2026.
  • The last three FCF Margin figures came in at 13.62% (Q1 2026), 13.44% (Q4 2025), and 23.01% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -
2 Teva Pharmaceutical Industries 43.07 Bn 39.42 Bn 2.15 Bn 7.41%
3 Zoetis 31.53 Bn 29.85 Bn 1.05 Bn 21.80%
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn 14.87%
5 United Therapeutics 22.13 Bn 19.47 Bn 683.80 Mn 26.25%
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn 8.76%
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn 13.41%
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 17.84%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Evolus 550.67 Mn 505.50 Mn 57.18 Mn -4.80%

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.80%
Mar 31, 2026 -13.62%
Dec 31, 2025 13.44%
Sep 30, 2025 -23.01%
Jun 30, 2025 -39.77%
Mar 31, 2025 -23.28%
Dec 31, 2024 5.54%
Sep 30, 2024 -8.88%
Jun 30, 2024 -11.28%
Mar 31, 2024 -18.32%
Dec 31, 2023 1.08%
Sep 30, 2023 -2.87%
Jun 30, 2023 -27.51%
Mar 31, 2023 -49.89%
Dec 31, 2022 -22.09%
Sep 30, 2022 -51.32%
Jun 30, 2022 -57.27%
Mar 31, 2022 -112.69%
Dec 31, 2021 -24.45%
Sep 30, 2021 -122.56%